Maha Sallam, Ph.D. is the founder and President of VuEssence, Inc. based in Tampa, Florida. VuEssence is focused on creating innovative solutions for aiding in the diagnoses and treatment of stroke and other neurological injuries. The company utilizes advanced molecular analysis technologies to develop specialized diagnostic devices.
Dr. Sallam is a graduate of the University of South Florida where she completed her undergraduate studies and subsequently earned her Master’s and Ph.D. degrees in Computer Engineering from the Department of Computer Science and Engineering. She later completed the Leadership and Strategy in Pharmaceuticals and Biotech Executive Education program at the Harvard Business School in Boston, Massachusetts.
Previously Dr. Sallam cofounded and led ISSI, Inc., a start-up company based in Tampa, FL, that successfully developed and commercialized image analysis solutions for Computer Aided Detection of breast cancer in mammograms. ISSI was later acquired by iCAD, Inc. (NASDAQ: iCAD) an industry-leading provider of cancer detection and treatment solutions headquartered in Nashua, New Hampshire. Dr. Sallam served on the Board of Directors of and held several management positions at iCAD where she continued to lead new product initiatives including Computer Aided Detection solutions for CT Colonography.
Dr. Sallam currently serves on the USF Department of Computer Science and Engineering Advisory Board and chairs the Board of Trustees for RVU College of Osteopathic Medicine. She also frequently mentors new entrepreneurs drawing on over 20 years of research and industry experience with a broad focus that spans research and development, clinical testing, regulatory approval and commercialization of new medical devices.